HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 384 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $590,763 | -54.8% | 15,465 | -54.8% | 0.07% | -70.8% |
| Q1 2023 | $1,305,831 | +69.7% | 34,193 | +152.9% | 0.24% | +32.1% |
| Q4 2022 | $769,288 | -6.1% | 13,520 | -34.8% | 0.18% | -1.1% |
| Q3 2022 | $819,000 | +13.9% | 20,724 | +26.8% | 0.19% | -3.6% |
| Q2 2022 | $719,000 | +59.8% | 16,342 | +47.7% | 0.19% | +31.3% |
| Q3 2021 | $450,000 | +86.0% | 11,065 | +90.3% | 0.15% | -1.3% |
| Q1 2021 | $242,000 | +13.1% | 5,815 | +16.0% | 0.15% | +13.7% |
| Q4 2020 | $214,000 | -29.4% | 5,015 | -56.4% | 0.13% | -42.0% |
| Q3 2020 | $303,000 | -24.1% | 11,515 | -22.6% | 0.23% | -55.2% |
| Q2 2020 | $399,000 | -80.2% | 14,884 | -86.9% | 0.50% | -18.4% |
| Q4 2019 | $2,020,000 | +503.0% | 113,958 | +170.3% | 0.62% | +852.3% |
| Q2 2013 | $335,000 | – | 42,166 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,829,337 | $266,308,000 | 10.60% |
| BB BIOTECH AG | 6,929,832 | $93,068,000 | 2.95% |
| SECTORAL ASSET MANAGEMENT INC | 2,671,051 | $35,872,000 | 1.64% |
| Sterling Global Strategies LLC | 22,000 | $295,000 | 1.63% |
| Lombard Odier Asset Management (USA) Corp | 1,061,547 | $14,257,000 | 1.24% |
| PYRRHO CAPITAL MANAGEMENT, LP | 90,000 | $1,209,000 | 1.04% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 8,184,003 | $109,911,000 | 0.93% |
| Bellevue Asset Management AG | 246,000 | $3,304,000 | 0.54% |
| Convergence Investment Partners, LLC | 251,748 | $3,381,000 | 0.39% |
| Rhenman & Partners Asset Management AB | 172,000 | $2,310,000 | 0.37% |